Meningococcal B Vaccine (MenB)

MenB protects against meningococcal group B — the group MenACWY does not cover. For healthy teens it is a shared decision at 16–23 years (preferably 16–18): 2 doses at least 6 months apart. For at-risk people it is a routine 3-dose series from age 10.

Teen Vaccines — illustrative image
Teen Vaccines — illustrative image
Who it is forAges 16–23 by shared decision; at-risk people from age 10
Vaccine typeProtein subunit (recombinant surface proteins) — not live
Doses2 doses, at least 6 months apart (healthy teens); 3 doses if at risk
Schedule sourceCDC child schedule, 2025

Group B is now one of the commonest causes of meningococcal disease in teenagers and young adults in the US, including outbreaks on college campuses. Its sugar coat resembles human tissue too closely to use in a vaccine, so MenB vaccines (Bexsero and Trumenba) are built from proteins on the bacterium's surface instead.

Because the disease is rare, the CDC frames MenB for healthy adolescents as a shared clinical decision — a conversation weighing a small individual risk against a safe, effective vaccine — rather than a universal routine recommendation. For people whose risk is clearly higher, it is recommended outright.

What this vaccine protects against

  • Meningococcal group B meningitis.
  • Meningococcal group B bloodstream infection (sepsis).

Who should get it, and when

Adolescents and young adults aged 16–23 years who are not at increased risk: vaccination based on shared clinical decision-making, preferably at 16–18 years — 2 doses of the same brand at least 6 months apart (if dose 2 is given sooner, a 3rd dose is needed at least 4 months later). A 3-dose schedule (0, 1–2, 6 months) may be used when faster protection is wanted, for example before starting college.

People aged 10 years and older at increased risk — no spleen or a damaged spleen, complement deficiency, complement-inhibitor medicines, microbiologists working with the bacterium, and people in an outbreak area — get a 3-dose series at 0, 1–2 and 6 months, plus boosters while the risk continues.

The same brand must be used for all doses. A combined MenACWY+MenB product (Penbraya) can be used from age 10 when both vaccines are due on the same day.

What happens at the vaccination visit

  • An injection into the upper arm.
  • MenB can be given at the same visit as MenACWY, at a different site.

How to prepare

  • Ask which brand is being used and record it — doses are not interchangeable between brands.
  • Tell the clinician about any spleen problem, complement deficiency or complement-inhibitor medicine, which move your teen from the shared-decision group into the recommended group.

What to expect afterwards

A sore arm is very common; headache, tiredness, muscle aches and mild fever occur more often than with many vaccines and usually settle in 1–3 days.

Who should not get it, or should ask first

  • A severe allergic reaction to a previous MenB dose or component is a contraindication.
  • Pregnancy: there are no adequate studies of MenB in pregnancy; CDC guidance is to defer unless the person is at increased risk and the benefit outweighs the risk — discuss with the clinician.
  • Moderate or severe illness is a reason to wait.

Benefits

  • Covers group B, the gap left by MenACWY, including the strains behind most campus outbreaks.
  • Particularly valuable for students entering dormitory living.

Limits and possible harms

  • Short-lived arm soreness and flu-like symptoms are common.
  • MenB strains vary, and the vaccines do not match every group B strain, so protection is broad but not total.

Watch: related videos

Useful links and tools

More in Teen Vaccines

Frequently asked questions

Why is MenB a 'shared decision' and not routine like MenACWY?

Meningococcal B disease is very rare, so for a healthy teenager the absolute benefit is small, while the vaccine is safe and effective. The CDC therefore recommends a conversation at 16–23 (preferably 16–18) rather than a blanket rule — and recommends it outright from age 10 for people at increased risk.

Can the two MenB brands be mixed?

No — the CDC notes specify the same brand (Bexsero or Trumenba) for all doses in the series. Keep the record of which brand was given.

This guide explains how a vaccine is usually given and who it is generally offered to, following the CDC immunization schedules. It is general educational information only — not medical advice, and not a recommendation for you personally. Whether a vaccine is right for you depends on your age, health and history, so talk to your own clinician or pharmacist. If you are ill now, seek medical care promptly rather than waiting for a vaccination appointment.

← Teen Vaccines · Vaccines & Immunization home